Ole Frilev Olesen

Prof. Dr. Ole Frilev Olesen

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
OOOle Frilev Olesen
Ole Frilev Olesen
LDLone Dagø
Lone Dagø

31 July 2018 in Globalization and Health
Verified
Journal Article
Open access
PDF file
TMTerra Morel
Terra Morel
DMDermot Maher
Dermot Maher
TNThomas Nyirenda
Thomas Nyirenda
OOOle Frilev Olesen
Ole Frilev Olesen
The objective was to guide key stakeholders on future directions of external funding of international postgraduate training (Master’s and PhD) of health research students at institutions in sub-Saharan Africa by mapping the numbers and characteristics of students, the location of institutions, and sources of external support. A cross-sectional survey of eligible external funding organizations and programmes was conducted in 2017. Information was gathered from funders’ websites or through the assistance of institutional contacts. The information requested included the number of Master’s and PhD grantees supported from January 2012 to June 2017, as well as each grantee’s institution of study, gender, country of origin and research area. Of 72 organizations contacted, there were 44 responses. Of the 44, 30 funders reported programmes within the inclusion criteria, and 19 funders provided data on relevant programmes. The Wellcome Trust, the International Development Research Centre and the Norwegian Agency for Development Cooperation supported the greatest number of grantees. There was concentrated support for grantees in eastern and southern Africa, countries with developed research capacity, and highly-developed research and training centres. More support was provided for PhD than Master’s degree programmes and for research areas more upstream along the research spectrum. Challenges were identified in recognizing relevant funding organizations and obtaining responses. Information was presented inconsistently across organizations, which were often unable to provide relevant and complete data within the survey timeframe. External funders should collect, analyse and report data at regular intervals on their support for strengthening postgraduate health research capacity in sub-Saharan Africa. Standardization of this process and development of an online database would not only help to avoid overlap between programmes and promote synergy between funders, but also inform dialogue between external funders and key stakeholders on strategic issues. These issues include how external funders can a) optimise their support for research capacity strengthening to maximise the benefits of research for health and development on an equitable basis, and b) optimise the distribution of support for researchers at different career stages and for research on different parts of the research spectrum to maximise the health benefits of research.

28 October 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
MKMandeep Kaur
Mandeep Kaur
LCLuca Coppeta
Luca Coppeta
OOOle Frilev Olesen
Ole Frilev Olesen
This study analyzes vaccine hesitancy (VH) among healthcare workers (HCWs) in 15 European countries. We have undertaken a systematic review by synthesizing data from 46 articles (between 2015 and 2022) encompassing 55,612 subjects. Despite the heterogeneity of the methods in the various studies, we found that physicians had consistently higher vaccination rates than nurses across different countries and different vaccines. Physicians’ average vaccination rate was 79% across a selection of vaccines, while that of nurses was 62%. Concerns regarding vaccine safety, information gaps, and the responsibility of healthcare authorities in managing VH are highlighted by qualitative insights. This research contributes to our comprehension of the ways in which VH among HCWs is impacted by healthcare roles, vaccine types, and regional disparities. The insights gleaned from this analysis can serve as a guide for targeted interventions aimed at increasing vaccine acceptance and coverage in Europe, ultimately strengthening public health.

1 September 2018 in The Lancet Global Health
Verified
Journal Article
Open access
MBMoses Bockarie
Moses Bockarie
SMShingai Machingaidze
Shingai Machingaidze
TNThomas Nyirenda
Thomas Nyirenda
OOOle Frilev Olesen
Ole Frilev Olesen
MMMichael Makanga
Michael Makanga

22 July 2019 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
GHGabriela Karolina Hajduk
Gabriela Karolina Hajduk
NJNina E Jamieson
Nina E Jamieson
BBBonny L Baker
Bonny L Baker
OOOle Frilev Olesen
Ole Frilev Olesen
TLTrudie Lang
Trudie Lang

1 January 2002 in Gene
Verified
Journal Article
Closed access
OOOle Frilev Olesen
Ole Frilev Olesen
HKHiromi Kawabata-Fukui
Hiromi Kawabata-Fukui
KYKatsutoshi Yoshizato
Katsutoshi Yoshizato
NNNobuhiro Noro
Nobuhiro Noro